6 completed, 2 suspended, 1 terminated, 1 unknown. 11 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 11 | Completed 6, Suspended 2, Terminated 1, Unknown 1, Withdrawn 1 |
Follow Otolith Labs: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Bone-Conducted Stimulation on Rotary Chair Time Constants in Patients With Vestibular Migraines Otolith Device Active, Otolith Device Inactive - Vestibular Migraine | Not applicable | Completed | Otolith Labs | 51 | 2024-08-27 | 2026-05-19 |
| SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines Otoband Experimental, Otoband Sham - Vestibular Migraine, Migraine Associated Vertigo | Not applicable | Completed | Otolith Labs | 322 | 2024-03-06 | 2025-01-30 |
| Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand Otoband Experimental, Otoband Sham - Vertigo, BPPV | Not applicable | Completed | Otolith Labs | 109 | 2023-02-02 | 2025-03-20 |
| Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy Otoband, Placebo Device - Dizziness, Nausea | Not applicable | Suspended | Otolith Labs | 40 | 2022-06-01 | 2022-03-22 |
| Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness Otoband, Placebo Device - Dizziness, Vertigo | Not applicable | Completed | Otolith Labs | 28 | 2021-11-04 | 2022-11-15 |
| Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting Otoband, Sham A, Sham B - Vertigo | Not applicable | Completed | Otolith Labs | 40 | 2021-04-19 | 2025-07-17 |
| Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus Otoband, Placebo - Tinnitus | Not applicable | Unknown | Otolith Labs | 40 | 2021-03-05 | 2022-03-22 |
| Prevention of Unmitigated Chemotherapy-induced Emesis Otoband, Placebo device - Chemotherapy-induced Nausea and Vomiting, Nausea Post Chemotherapy | Not applicable | Withdrawn | Otolith Labs | 2019-08-01 | 2021-04-27 | |
| Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo Otoband, Otoband sham - Dizziness, Nausea | Not applicable | Suspended | Otolith Labs | 40 | 2019-04-26 | 2021-04-27 |
| Transcranial Vibrating System for Improving Vestibular Physical Therapy Transcranial vibrating system, Transcranial vibrating system sham - Vertigo, Dizziness | Not applicable | Terminated | Otolith Labs | 1 | 2019-01-01 | 2022-04-01 |
| Efficacy of a Transcranial Vibrating System for Minimizing Dizziness During Caloric Testing Efficacy of transcranial vibrating system on mitigating dizziness and nausea during caloric testing - Vestibular Function Tests, Dizziness | Not applicable | Completed | Otolith Labs | 39 | 2018-10-01 | 2025-02-06 |
Dizziness (5) · Nausea (4) · Vertigo (4) · Meniere Disease (3) · Labyrinthitis (2) · Vestibular Neuronitis (2) · Benign Paroxysmal Positional Vertigo (1) · Confusion (1) · Headache (1) · Tinnitus (1) · Vestibular Diseases (1) · Vomiting (1)
United States (11)
Didier Depireux, PhD (7) · Brooke Pearce, AuD (1) · David J Eisenman, MD (1) · Dennis Fitzgerald, MD (1) · Michael S Sherman, MD (1)